Home › Kanker (alle vormen) › Texas › Dallas
Kanker (alle vormen) klinische studies in Dallas, TX
37 studies voor Kanker (alle vormen) zoeken deelnemers op locaties in en rond Dallas (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekruterenObservatieonderzoek
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
RekruterenFase 1
- GSK Investigational Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruterenFase 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- en nog 1
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RekruterenFase 1
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekruterenFase 3
- Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruterenFase 2/3
- Texas Oncology, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- UT Southwestern Medical Center, Dallas
Connect for Cancer Prevention Study (Connect)
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Baylor Scott and White Health, Dallas
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
RekruterenFase 2
- UT Southwestern Medical Center, Dallas
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekruterenFase 1/2
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
Falcon Real World Evidence Registry
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Baylor Scott & White Health, Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruterenFase 1
- Mary Crowley Cancer Research, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer
RekruterenFase 1
- University of Texas Southwestern Medical Center, Dallas
Project: Every Child for Younger Patients With Cancer
RekruterenObservatieonderzoek
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekruterenFase 3
- University of Texas Southwestern, Dallas
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RekruterenFase 2
- University of Texas Southwestern Medical Center at Dallas, Dallas
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RekruterenFase 1
- Mary Crowley Cancer Research Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruterenFase 1/2
- University of Texas - Southwestern Medical Center /ID# 274360, Dallas
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruterenFase 1
- Texas Oncology - Dallas - Worth Street /ID# 280064, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RekruterenObservatieonderzoek
- Liver Center of Texas, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
RekruterenFase 2
- University of Texas Southwestern Medical Center, Dallas
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
RekruterenVroege fase 1
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekruterenFase 1
- GSK Investigational Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekruteren
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruterenFase 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekruterenFase 1/2
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
RekruterenFase 1
- GSK Investigational Site, Dallas
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
RekruterenFase 2
- Texas Oncology, Dallas
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
RekruterenObservatieonderzoek
- UT Southwestern Medical Centre, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- NEXT Dallas, Dallas
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
RekruterenObservatieonderzoek
- Baylor University Medical Center - Dallas, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RekruterenFase 1
- NEXT Dallas, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
RekruterenFase 2
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Dallas
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RekruterenObservatieonderzoek
- UT Southwestern, Dallas
Kanker (alle vormen) studies in andere steden
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Andere studies in Dallas
- Borstkanker55 studies
- Niet-kleincellige longkanker52 studies
- Metastatische kanker42 studies
- Hartfalen42 studies
- Prostaatkanker36 studies
- Colorectale kanker33 studies
- Obesitas30 studies
- Eierstokkanker28 studies
- Blasenkanker27 studies
- Longkanker27 studies
- Endometriumkanker24 studies
- Cardiovasculaire ziekte23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.